The North America And Europe Dermal Filler Market, estimated at USD 2,540.4 Mn in 2025, is expected to exhibit a CAGR of 6.9% and reach USD 4,052.7 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The advent of newer dermal filler products is expected to provide lucrative growth opportunities for players. Thus, key market players are focused on adopting growth strategies such as research and development activities, which will drive the North America and Europe Dermal Fillers Market. For example, in February 22, 2025 Merz Aesthetics a U.S.-based aesthetic device company, launched New Belotero Balance (+) With Lidocaine, which is used to smooth moderate-to-severe etched-in facial lines and wrinkles in the lower face. Belotero Balance (+) offers the benefits of hyaluronic acid plus the advantages of a lidocaine formulation.
North America and Europe Dermal Fillers Market – Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: the manufacturing and distribution of products due to lockdown, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Also due to social distancing, the procedures were reduced. Due to the lockdown, several countries faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a negative impact on the North America and Europe Dermal Fillers Market. This is because less manufacturing and demand of dermal filler products during pandemic situation. For instance, according to global revenue of Juvederm, a product of allergen aesthetics, a U.S.-based pharmaceutical company was reduced by 40.2 % in 2025 compared to previous year. Revenue in year 2025 was US$ 718 Mn while it was nearly US$ 1,243.7 Mn in 2025.
North America and Europe Dermal Fillers Market: Key Developments
Clinical trials carried out across the world are expected to boost market growth during the forecast period. For instance, according to data published on December 3, 2025, on clinical trial site of U.S. National Library of Medicine, currently clinical trials are being carried out by Dr. Korman Laboratories Ltd., an Israel based aesthetic medicine company on Safety and Performance of Depolymerized kraft lignin Crosslinked Sodium Hyaluronate 23 Dermal Filler for improvement of nasolabial fold Appearance, which started in 2025.
Browse 21 Market Data Tables and 19 Figures spread through 140 Pages and in-depth TOC on “North America and Europe Dermal Fillers Market”- Forecast to 2032, North America and Europe Dermal Fillers Market, by Product (absorbable and non-absorbable) and Ingredients, (Hyaluronic acid, Poly-L- Lactic acid, Calcium Hydroxylapatite, Polymethylmethacrylate, Collagen), by Distribution channel (Retail pharmacies and drug stores, clinics and hospital pharmacies, and online sales) and by Region (North America, Western Europe, Eastern Europe)
To know the latest trends and insights prevalent in this market, click the link below:
Key Takeaways of the North America and Europe Dermal Fillers Market:
- The North America and Europe Dermal Fillers Market is expected to exhibit a CAGR of 6.9% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the North America and Europe Dermal Fillers Market. For instance, On February 8, 2025 CollPlant, an Israel-based biotechnology company, announced development and global commercialization agreement with Allergan Aesthetics, an Ireland-based company for rhCollagen in dermal and soft tissue filler products.
- Among ingredients, the hyaluronic acid segment is expected to grow in the North America and Europe Dermal Fillers Market over the forecast period. This is due to approval of newer Hyaluronic acid based products by U.S. FDA. For instance, in August 2025, JUVÉDERM VOLUX XC , a hyaluronic acid (HA) filler to receive U.S. FDA approval for improving jawline definition.
- Among region, North America is expected to be the dominant region in the North America and Europe Dermal Fillers Market , owing to the increasing research and development activities. For instance, Galderma Receives U.S. FDA Approval For Restylane Kysse, A New Hyaluronic Acid (HA) filler designed and indicated to add fullness to the lips and help smooth the wrinkles above the mouth.
- Major players operating in the North America and Europe Dermal Fillers Market include Galderma Pharma S.A., Sinclair Pharma plc., Allergan Plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH, and Laboratoires Vivacy SAS.
Contact Us